Oragenics Inc.
Symbol: OGEN (NYSE)
1.29
▲ (0.39%) 0.005
Company Description:
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
Key Stats
- Today's Open: $1.29
- Today's High: $1.295
- Today's Low: $1.285
- Today's Volume: 3.39K
- Yesterday Close: $1.28
- Yesterday High: $1.3098
- Yesterday Low: $1.26
- Yesterday Volume: 44.68K
- Last Min Volume: 50
- Last Min High: $1.285
- Last Min Low: $1.285
- Last Min VWAP: $1.285
Company Profile
- Name: Oragenics Inc.
- Website: https://www.oragenics.com
- Listed Date: 2003-07-03
- Location: SARASOTA, FL
- Market Status: Active
- CIK Number: 0001174940
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $5.65M
- Round Lot: 100
- Outstanding Shares: 4.13M
- Asset Type: CS
RECENT FILINGS FOR OGEN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-21 | 8-K | View |
| 2025-09-02 | 8-K | View |
| 2025-09-02 | 3 | View |
| 2025-08-26 | S-8 | View |
| 2025-08-11 | 8-K | View |
| 2025-08-08 | 10-Q | View |
| 2025-07-02 | 8-K | View |
| 2025-07-02 | SCHEDULE 13G | View |
| 2025-07-02 | 424B5 | View |
| 2025-06-30 | EFFECT | View |
| 2025-06-30 | S-1/A | View |
| 2025-06-26 | CORRESP | View |
| 2025-06-26 | CORRESP | View |
| 2025-06-23 | CORRESP | View |
| 2025-06-23 | S-1 | View |
| 2025-06-18 | 4 | View |
| 2025-06-17 | UPLOAD | View |
| 2025-06-16 | 4 | View |
| 2025-06-16 | 3 | View |
| 2025-06-13 | 144 | View |
Latest News on OGEN